Safety, Tolerability and Pharmacokinetics of EB-203 Eye Drops in Healthy Volunteers
Clinical trial NCT05538949 · COMPLETED
Trial details
- NCT number
- NCT05538949
- Sponsor
- EyebioKorea, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-29
- Primary completion
- 2022-10-07
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.